Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA

References

• Ahmed F, Pakunlu RI, Brannan A, Bates F, Minko T, Discher DE. (2006). Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug. J Control Release, 116, 150–158.
   PubMed Web of Science ®Google Scholar
• Anderson ME. (1998). Glutathione: An overview of biosynthesis and modulation. Chem Biol Interact, 111–112, 1–14.
   PubMed Web of Science ®Google Scholar
• Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA; Gynecologic Oncology Group. (2006). Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med, 354, 34–43.
   PubMed Web of Science ®Google Scholar
• Aziz Z, Zahid M, Ud Din Ahmed Z, Arshad T. (1998). Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer. Aust N Z J Med, 28, 403–409.
   PubMedGoogle Scholar
• Bareford LM, Swaan PW. (2007). Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev, 59, 748–758.
   PubMed Web of Science ®Google Scholar
• Beck-Broichsitter M, Gauss J, Packhaeuser CB, Lahnstein K, Schmehl T, Seeger W, Kissel T, Gessler T. (2009). Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model. Int J Pharm, 367, 169–178.
   PubMed Web of Science ®Google Scholar
• Bilgi O, Karagoz B, Alacacioglu A, Ozgun A, Tuncel T, Gokhan-Kandemir E. (2010). Irinotecan and cisplatin vs. cyclophosphamide, doxorubicin, and vincristine as second-line treatment after platinum and etoposide in small-cell lung cancer. J BUON, 15, 395.
   PubMed Web of Science ®Google Scholar
• Borm PJ, Kreyling W. (2004). Toxicological hazards of inhaled nanoparticles–potential implications for drug delivery. J Nanosci Nanotechnol, 4, 521–531.
   PubMed Web of Science ®Google Scholar
• Bravo-Osuna I, Teutonico D, Arpicco S, Vauthier C, Ponchel G. (2007). Characterization of chitosan thiolation and application to thiol quantification onto nanoparticle surface. Int J Pharm, 340, 173–181.
   PubMed Web of Science ®Google Scholar
• Bunn PAJr. (2004). Early-stage non-small-cell lung cancer: Current perspectives in combined-modality therapy. Clin Lung Cancer, 6, 85–98.
   PubMedGoogle Scholar
• Chandna P, Saad M, Wang Y, Ber E, Khandare J, Vetcher AA, Soldatenkov VA, Minko T. (2007). Targeted proapoptotic anticancer drug delivery system. Mol Pharm, 4, 668–678.
   PubMed Web of Science ®Google Scholar
• Chen AM, Zhang M, Wei D, Stueber D, Taratula O, Minko T, He H. (2009). Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small, 5, 2673–2677.
   PubMed Web of Science ®Google Scholar
• Chen SH, Zhaori G. (2011). Potential clinical applications of siRNA technique: Benefits and limitations. Eur J Clin Invest, 41, 221–232.
   PubMed Web of Science ®Google Scholar
• Densmore CL. (2003). The re-emergence of aerosol gene delivery: A viable approach to lung cancer therapy. Curr Cancer Drug Targets, 3, 275–286.
   PubMed Web of Science ®Google Scholar
• Dharap SS, Minko T. (2003). Targeted proapoptotic LHRH-BH3 peptide. Pharm Res, 20, 889–896.
   PubMed Web of Science ®Google Scholar
• Dharap SS, Qiu B, Williams GC, Sinko P, Stein S, Minko T. (2003). Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J Control Release, 91, 61–73.
   PubMed Web of Science ®Google Scholar
• Dharap SS, Wang Y, Chandna P, Khandare JJ, Qiu B, Gunaseelan S, Sinko PJ, Stein S, Farmanfarmaian A, Minko T. (2005). Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc Natl Acad Sci USA, 102, 12962–12967.
   PubMed Web of Science ®Google Scholar
• du Bois A, Neijt JP, Thigpen JT. (1999). First line chemotherapy with carboplatin plus paclitaxel in advanced ovarian cancer–a new standard of care? Ann Oncol, 10 Suppl 1, 35–41.
   PubMed Web of Science ®Google Scholar
• Fotin-Mleczek M, Fischer R, Brock R. (2005). Endocytosis and cationic cell-penetrating peptides–a merger of concepts and methods. Curr Pharm Des, 11, 3613–3628.
   PubMed Web of Science ®Google Scholar
• Gaber MH, Hong K, Huang SK, Papahadjopoulos D. (1995). Thermosensitive sterically stabilized liposomes: Formulation and in vitro studies on mechanism of doxorubicin release by bovine serum and human plasma. Pharm Res, 12, 1407–1416.
   PubMed Web of Science ®Google Scholar
• Garbuzenko OB, Saad M, Betigeri S, Zhang M, Vetcher AA, Soldatenkov VA, Reimer DC, Pozharov VP, Minko T. (2009). Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug. Pharm Res, 26, 382–394.
   PubMed Web of Science ®Google Scholar
• Garbuzenko OB, Saad M, Pozharov VP, Reuhl KR, Mainelis G, Minko T. (2010). Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance. Proc Natl Acad Sci USA, 107, 10737–10742.
   PubMed Web of Science ®Google Scholar
• Gautam A, Koshkina N. (2003). Paclitaxel (taxol) and taxoid derivates for lung cancer treatment: Potential for aerosol delivery. Curr Cancer Drug Targets, 3, 287–296.
   PubMed Web of Science ®Google Scholar
• Gross A, McDonnell JM, Korsmeyer SJ. (1999). BCL-2 family members and the mitochondria in apoptosis. Genes Dev, 13, 1899–1911.
   PubMed Web of Science ®Google Scholar
• Gu J, Su S, Li Y, He Q, Zhong J, Shi J. (2010). Surface modification−complexation strategy for cisplatin loading in mesoporous nanoparticles. J Phys Chem Lett, 1, 3446–3450.
   Web of Science ®Google Scholar
• Guo J, Fisher KA, Darcy R, Cryan JF, O’Driscoll C. (2010). Therapeutic targeting in the silent era: Advances in non-viral siRNA delivery. Mol Biosyst, 6, 1143–1161.
   PubMed Web of Science ®Google Scholar
• He Q, Zhang J, Shi J, Zhu Z, Zhang L, Bu W, Guo L, Chen Y. (2010). The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials, 31, 1085–1092.
   PubMed Web of Science ®Google Scholar
• Hillaireau H, Couvreur P. (2009). Nanocarriers’ entry into the cell: Relevance to drug delivery. Cell Mol Life Sci, 66, 2873–2896.
   PubMed Web of Science ®Google Scholar
• Huang Y, Park YS, Wang J, Moon C, Kwon YM, Chung HS, Park YJ, Yang VC. (2010). ATTEMPTS system: A macromolecular prodrug strategy for cancer drug delivery. Curr Pharm Des, 16, 2369–2376.
   PubMed Web of Science ®Google Scholar
• Jaracz S, Chen J, Kuznetsova LV, Ojima I. (2005). Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem, 13, 5043–5054.
   PubMed Web of Science ®Google Scholar
• Jung S, Lee SH, Mok H, Chung HJ, Park TG. (2010). Gene silencing efficiency of siRNA-PEG conjugates: Effect of PEGylation site and PEG molecular weight. J Control Release, 144, 306–313.
   PubMed Web of Science ®Google Scholar
• Koshkina NV, Waldrep JC, Roberts LE, Golunski E, Melton S, Knight V. (2001). Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model. Clin Cancer Res, 7, 3258–3262.
   PubMed Web of Science ®Google Scholar
• Koshkina NV, Waldrep JC, Knight V. (2003). Camptothecins and lung cancer: Improved delivery systems by aerosol. Curr Cancer Drug Targets, 3, 251–264.
   PubMed Web of Science ®Google Scholar
• Kwon G, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K. (1997). Block copolymer micelles for drug delivery: Loading and release of doxorubicin. J Control Release, 48, 195–201.
   Web of Science ®Google Scholar
• Laitala-Leinonen T. (2010). Update on the development of microRNA and siRNA molecules as regulators of cell physiology. Recent Pat DNA Gene Seq, 4, 113–121.
   PubMedGoogle Scholar
• Lin YS, Tsai CP, Huang HY, Kuo CT, Hung Y, Huang DM, Chen YC, Mou CY. (2005). Well-ordered mesoporous silica nanoparticles as cell markers. Chemistry of Materials, 17, 4570–4573.
   Web of Science ®Google Scholar
• March TH, Marron-Terada PG, Belinsky SA. (2001). Refinement of an orthotopic lung cancer model in the nude rat. Vet Pathol, 38, 483–490.
   PubMed Web of Science ®Google Scholar
• Martins RG. (2005). Treatment of locally advanced non-small cell lung cancer with combination of chemotherapy and radiation. Semin Respir Crit Care Med, 26, 273–277.
   PubMed Web of Science ®Google Scholar
• McNiven MA. (2006). Big gulps: Specialized membrane domains for rapid receptor-mediated endocytosis. Trends Cell Biol, 16, 487–492.
   PubMed Web of Science ®Google Scholar
• Melani AS. (2007). Inhalatory therapy training: A priority challenge for the physician. Acta Biomed, 78, 233–245.
   PubMedGoogle Scholar
• Minko T, Dharap SS, Pakunlu RI, Wang Y. (2004). Molecular targeting of drug delivery systems to cancer. Curr Drug Targets, 5, 389–406.
   PubMed Web of Science ®Google Scholar
• Minna JD, Schiller, JH. (2008). Harrison’s principles of internal medicine. McGraw-Hill. pp. 551–562.
   Google Scholar
• Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. (2008). Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc, 83, 584–594.
   PubMed Web of Science ®Google Scholar
• Muggia FM, Jeffers S, Muderspach L, Roman L, Rosales R, Groshen S, Safra T, Morrow CP. (1997). Phase I/II study of intraperitoneal floxuridine and platinums (cisplatin and/or carboplatin). Gynecol Oncol, 66, 290–294.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Ghosh RN, Maxfield FR. (1997). Endocytosis. Physiol Rev, 77, 759–803.
   PubMed Web of Science ®Google Scholar
• Nguyen J, Steele TW, Merkel O, Reul R, Kissel T. (2008). Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy. J Control Release, 132, 243–251.
   PubMed Web of Science ®Google Scholar
• Pakunlu RI, Cook TJ, Minko T. (2003). Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin. Pharm Res, 20, 351–359.
   PubMed Web of Science ®Google Scholar
• Pakunlu RI, Wang Y, Tsao W, Pozharov V, Cook TJ, Minko T. (2004). Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: Novel multicomponent delivery system. Cancer Res, 64, 6214–6224.
   PubMed Web of Science ®Google Scholar
• Pakunlu RI, Wang Y, Saad M, Khandare JJ, Starovoytov V, Minko T. (2006). In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug. J Control Release, 114, 153–162.
   PubMed Web of Science ®Google Scholar
• Parra HS, Tixi L, Latteri F, Bretti S, Alloisio M, Gravina A, Lionetto R, Bruzzi P, Dani C, Rosso R, Cosso M, Balzarini L, Santoro A, Ardizzoni A. (2001). Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: A Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP). Cancer, 92, 650–656.
   PubMed Web of Science ®Google Scholar
• Perry CC. (2009). An overview of silica in biology: Its chemistry and recent technological advances. Prog Mol Subcell Biol, 47, 295–313.
   PubMedGoogle Scholar
• Pinmai K, Chunlaratthanabhorn S, Ngamkitidechakul C, Soonthornchareon N, Hahnvajanawong C. (2008). Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: Doxorubicin and cisplatin against human hepatocellular carcinoma and lung cancer cells. World J Gastroenterol, 14, 1491–1497.
   PubMed Web of Science ®Google Scholar
• Radu DR, Lai CY, Jeftinija K, Rowe EW, Jeftinija S, Lin VS. (2004). A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J Am Chem Soc, 126, 13216–13217.
   PubMed Web of Science ®Google Scholar
• Reed JC. (1999). Dysregulation of apoptosis in cancer. J Clin Oncol, 17, 2941–2953.
   PubMed Web of Science ®Google Scholar
• Reference PD. (2007). Taxotere. Physicians Desk Reference, 61, 2932–2943.
   Google Scholar
• Saad M, Garbuzenko OB, Ber E, Chandna P, Khandare JJ, Pozharov VP, Minko T. (2008). Receptor targeted polymers, dendrimers, liposomes: Which nanocarrier is the most efficient for tumor-specific treatment and imaging? J Control Release, 130, 107–114.
   PubMed Web of Science ®Google Scholar
• Saad M, Garbuzenko OB, Minko T. (2008). Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. Nanomedicine (Lond), 3, 761–776.
   PubMed Web of Science ®Google Scholar
• Savla R, Taratula O, Garbuzenko O, Minko T. (2011). Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. J Control Release, 153, 16–22.
   PubMed Web of Science ®Google Scholar
• Shi Q, Zhang XL, Dai KR, Benderdour M, Fernandes JC. (2011). siRNA therapy for cancer and non-lethal diseases such as arthritis and osteoporosis. Expert Opin Biol Ther, 11, 5–16.
   PubMed Web of Science ®Google Scholar
• Slowing II, Wu CW, Vivero-Escoto JL, Lin VS. (2009). Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small, 5, 57–62.
   PubMed Web of Science ®Google Scholar
• Slowing II, Trewyn BG, Lin VS. (2007). Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J Am Chem Soc, 129, 8845–8849.
   PubMed Web of Science ®Google Scholar
• Sun L, Yu C, Irudayaraj J. (2007). Surface-enhanced Raman scattering based nonfluorescent probe for multiplex DNA detection. Anal Chem, 79, 3981–3988.
   PubMed Web of Science ®Google Scholar
• Tao Z, Xie Y, Goodisman J, Asefa T. (2010). Isomer-dependent adsorption and release of cis- and trans-platin anticancer drugs by mesoporous silica nanoparticles. Langmuir, 26, 8914–8924.
   PubMed Web of Science ®Google Scholar
• Taratula O, Garbuzenko OB, Kirkpatrick P, Pandya I, Savla R, Pozharov VP, He H, Minko T. (2009). Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. J Control Release, 140, 284–293.
   PubMed Web of Science ®Google Scholar
• Taratula O, Garbuzenko O, Savla R, Wang YA, He H, Minko T. (2011). Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes. Curr Drug Deliv, 8, 59–69.
   PubMed Web of Science ®Google Scholar
• Taylor A, Krupskaya Y, Krämer K, Füssel S, Klingeler R, Büchner B, Wirth MP. (2010). Cisplatin-loaded carbon-encapsulated iron nanoparticles and their in vitro effects in magnetic fluid hyperthermia. Carbon, 48, 2327–2334.
   Web of Science ®Google Scholar
• Tokatlian T, Segura T. (2010). siRNA applications in nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2, 305–315.
   PubMed Web of Science ®Google Scholar
• Valle MJ, González López F, Sánchez Navarro A. (2008). Pulmonary versus systemic delivery of levofloxacin. The isolated lung of the rat as experimental approach for assessing pulmonary inhalation. Pulm Pharmacol Ther, 21, 298–303.
   PubMed Web of Science ®Google Scholar
• de Jesús Valle MJ, López FG, Hurlé AD, Navarro AS. (2007). Pulmonary versus systemic delivery of antibiotics: Comparison of vancomycin dispositions in the isolated rat lung. Antimicrob Agents Chemother, 51, 3771–3774.
   PubMed Web of Science ®Google Scholar
• Vivero-Escoto JL, Slowing II, Trewyn BG, Lin VS. (2010). Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small, 6, 1952–1967.
   PubMed Web of Science ®Google Scholar
• Xu M, Sheng LH, Zhu XH, Zeng SB, Zhang GJ. (2010). Reversal effect of Stephania tetrandra-containing Chinese herb formula SENL on multidrug resistance in lung cancer cell line SW1573/2R120. Am J Chin Med, 38, 401–413.
   PubMed Web of Science ®Google Scholar
• Yi D, Wiedmann TS. (2010). Inhalation adjuvant therapy for lung cancer. J Aerosol Med Pulm Drug Deliv, 23, 181–187.
   PubMed Web of Science ®Google Scholar
• Youlden DR, Cramb SM, Baade PD. (2008). The International Epidemiology of Lung Cancer: Geographical distribution and secular trends. J Thorac Oncol, 3, 819–831.
   PubMed Web of Science ®Google Scholar
• Yu J, Chien YW. (1997). Pulmonary drug delivery: Physiologic and mechanistic aspects. Crit Rev Ther Drug Carrier Syst, 14, 395–453.
   PubMed Web of Science ®Google Scholar
• Zaki NM, Tirelli N. (2010). Gateways for the intracellular access of nanocarriers: A review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting. Expert Opin Drug Deliv, 7, 895–913.
   PubMed Web of Science ®Google Scholar